Selective extraction of proteins and other macromolecules from biological samples using molecular imprinted polymers by Stevenson, D et al.
Article
Selective extraction of proteins and other 
macromolecules from biological samples using 
molecular imprinted polymers
Stevenson, D, EL-Sharif, H and Reddy, Subrayal M
Available at http://clok.uclan.ac.uk/15732/
Stevenson, D, EL­Sharif, H and Reddy, Subrayal M (2016) Selective extraction of proteins and 
other macromolecules from biological samples using molecular imprinted polymers. Bioanalysis, 
8 (21). pp. 2255­2263. ISSN 1757­6180  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.4155/bio-2016-0209
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
Selective extraction of proteins and other macromolecules from 1 
biological samples using molecular imprinted polymers 2 
Derek Stevenson*,1, Hazim F EL-Sharif1 & Subrayal M Reddy2 3 
1Chemistry Department, University of 4 
Surrey, Guildford, Surrey, GU2 7XH, UK 5 
2Chemistry Division, University of 6 
Central Lancashire, Preston, Lancashire, 7 
PR1 2HE, UK 8 
*Author for correspondence: 9 
d.stevenson@surrey.ac.uk 10 
11 
Background 12 
The determination of drugs, metabolites and biomarkers in biological samples 13 
continues to present one of the most difficult challenges to analytical scientists. 14 
Matrices such as plasma, serum, blood, urine or tissues for example, usually 15 
contain the analyte(s) of interest at low concentration in the presence of many 16 
other components which may interfere directly or indirectly with the accurate 17 
determination of species and concentration. Historically, the most common 18 
methods have involved some form of extraction or isolation such as liquid-liquid 19 
extraction (LLE), solid phase extraction (SPE) or protein precipitation. For a 20 
recent review of sample preparation methods for bioanalysis, see [1]. This 21 
includes comments on costs, automation, and miniaturisation with an overall 22 
focus on productivity.  23 
 24 
Accurate quantitative measurement over the last 40 years has traditionally been 25 
carried out by chromatography, mainly high performance liquid chromatography 26 
(HPLC) and occasionally gas chromatography (GC). Although a range of 27 
detectors has been available for both, most typically, HPLC used ultraviolet (UV) 28 
and GC used flame ionisation and then both have used mass spectrometry (MS). 29 
Sample preparation has been usually by a variant of LLE, SPE or protein 30 
precipitation [2]. As the need for greater sensitivity has been a constant 31 
challenge, sophisticated and more selective methods of sample preparation have 32 
been explored. One of the most attractive of these has been the use of 33 
immobilised antibodies [3] to selectively extract drugs and metabolites in a typical 34 
SPE format. Many examples have been published but the approach has been 35 
limited by a number of factors such as cost and uncertainty of antibody 36 
production as well as stability of the antibodies. Significant developments 37 
overcoming the coupling of MS to HPLC and its subsequent widespread use has 38 
meant that the demands on sample preparation have been reduced. As drugs 39 
and metabolites are typically small molecular mass organic compounds greater 40 
selectivity and sensitivity could be achieved by the end step measuring 41 
technique, and there has indeed been wide uptake of this technology especially 42 
in the pharmaceutical industry.  43 
 44 
Molecularly imprinted polymers  45 
Nevertheless, within the bioanalytical community the interest in the advantages 46 
offered by selective extraction have remained. Molecularly imprinted polymers 47 
(MIPs) have been suggested as an alternative to immobilised antibodies in a 48 
number of areas including bioanalysis [4] as these are potentially much cheaper 49 
to synthesise and more stable than biological antibodies.  MIPs have been the 50 
subject of numerous reviews [5, 6] so the basic principles will only be 51 
summarised here. Briefly, the preparation involves a reaction mixture containing 52 
the analyte (the so-called template molecule), a functional monomer, a cross-53 
linking agent and an initiator in a suitable solvent. The MIP is formed around the 54 
template. The template is subsequently removed leaving cavities that can 55 
selectively rebind the template. The aim is to create a reagent (MIP) that can 56 
selectively bind the analyte, in a similar way to an antibody. Immobilized 57 
antibodies can be very specific but they are inherently quite fragile molecules, 58 
particularly when exposed to organic solvents, pH values of more than 2-3 units 59 
from neutral and/or heat. They can also be quite time-consuming to produce, in 60 
many cases requiring repeated dosing to animals, with no certainty that useful 61 
antibodies will eventually be obtained. In contrast, MIPs are produced rapidly in 62 
the chemistry laboratory and use well-established synthetic routes which lead to 63 
comparatively lower production costs. They are more stable over a wider pH 64 
range and can be used with a broader range of solvents. This potentially also 65 
offers the advantage that they could be re-usable, further lowering the costs.   66 
 67 
Many papers and reviews have been written on the optimisation of conditions, 68 
different methods of characterisation and different uses of MIPs [7-9]. In many 69 
cases, the MIPs will only perform their selective capture if they are in the solvent 70 
used for their preparation. The importance of buffer conditioning has been 71 
emphasised [9]. For example, MIPs have been proposed as offering advantages 72 
as columns for HPLC, SPE [2, 3, 10, 11], capillary electrophoresis [12] and 73 
electrochromatography, replacing antibodies in enzyme-linked immunosorbent 74 
assay (ELISA) tests [13], artificial enzymes or receptors, recognition elements 75 
within sensors [14], selective drug delivery, catalysts and to aid crystallization 76 
[15].  The area of SPE has attracted most attention and new approaches are still 77 
being reported in this area. The development of nanoparticles has led to 78 
molecular imprinting onto the surface of magnetic nanoparticles [16] followed by 79 
solid phase microextraction (SPME) or ultrasonic assisted SPME [17-19] and 80 
matrix dispersant SPME [20, 21]. MIPs which are integrated with magnetic 81 
nanoparticles offers the added advantage of a simple separation using a magnet 82 
following the selective template (analyte) binding/extraction step. Ding et al. 2014 83 
[22]  has written a recent review on surface imprinting technologies for nano-84 
MIPs. This described both small and large molecule templates in two different 85 
sections. Examples of biomacromolecules that have been imprinted include 86 
lysozyme, bovine haemoglobin, human haemoglobin, amylase and bovine serum 87 
albumin (BSA) as well as virus particles.  88 
 89 
The preponderance of reviews on the use of MIPs for separation science has led 90 
to a review of reviews [23]. Nonetheless the use of commercially available MIPs 91 
using validated methods for bioanalysis is not considered commonplace. Li et al. 92 
2014 [24] has written an extensive review on macromolecules concentrating on 93 
proteins, carbohydrates, DNA, viruses and cells. The review contrasts the 94 
development of small molecular mass versus macromolecule templates. 95 
Progress with the latter has been slower and unremarkable. Several commercial 96 
companies are producing MIPs for SPE mainly for small molecular mass analytes 97 
such as drugs and pesticides. These however are not commonplace. 98 
 99 
Many of the applications published in scientific literature consider only the 100 
comparison of a MIP with a non-imprinted polymer (NIP), along with comparisons 101 
of a very small number of other related compounds as evidence of a MIP effect. 102 
Studies looking at the rebinding of the analyte to the MIP compared to a NIP are 103 
commonplace. In many applications the MIPs will often only work satisfactorily 104 
when the rebinding is carried out in the solvent in which the MIP was 105 
synthesised, typically organic solvents. This is a considerable drawback when the 106 
need is to extract from aqueous biological fluids such as plasma, serum, urine, 107 
tissue extracts and faeces. It is also unsuitable for most macromolecules of 108 
biological interest as they are not stable in organic solvents. Biologicals (greater 109 
than 1000 Da) are metastable and can undergo intra-molecularly-induced 110 
changes in conformation depending on their chemical environment. They 111 
therefore need to be exposed to less harsh polymerisation conditions compared 112 
with the imprinting of small and robust molecules (less than 700 Da) the latter 113 
inherently possessing less degrees of freedom in molecular arrangement. MIP 114 
preparations for biologicals have therefore focused on the use of water-115 
compatible polymers, namely hydrogels based on using acrylamide (AAm)  as a 116 
functional monomer [25-27] and the repertoire extended more recently using a 117 
combination of acrylo-based functional monomers to polymerise in the presence 118 
of a second (more biocompatible) polymer including polyethylene glycol (PEG) 119 
and chitosan [28]. Chitosan is a derivative of chitin (extracted from crustacean 120 
species), and is produced by deacetylation of chitin under alkaline conditions. At 121 
around physiological pH and below, chitosan is positively charged. Thus in 122 
addition to the generally accepted hydrogen bonding interactions and cavity fit 123 
offered by MIPs, the presence of positive charge offers an additional 124 
(electrostatic) anchor for the imprinting of proteins. 125 
 126 
MIPs for extraction/enrichment of macromolecules 127 
One area of growing interest in bioanalysis has been in the preparation of MIPs 128 
to peptides, proteins or other large biomolecules [29, 30]. The changing nature of 129 
drug development suggests that macromolecules are increasingly being 130 
proposed as new therapeutic agents or indeed as biomarkers for a range of 131 
diseases. Novel approaches for their reliable accurate measurement is thus of 132 
growing interest. In many cases the macromolecules will be present in biological 133 
fluids at low concentrations so the application of MIPs for selective extraction to 134 
allow pre-concentration and clean-up is a very attractive approach.  The 135 
development of such MIPs using protein templates was reviewed [31]. The latter 136 
review was focused on sensors but the methods used to prepare the MIPs 137 
should be a useful guide for their eventual application in selective enrichment or 138 
other applications. The review discussed template selection, bulk compared with 139 
surface imprinting, the use of whole protein or epitopes, solvent conditions used 140 
for imprinting, the choice of monomers and cross-linkers, procedures for template 141 
removal as well as the sensor development aspects, Many of the examples of 142 
MIPs for proteins use a low degree of cross-linking to give soft hydrogels rather 143 
than the highly cross-linked rigid gels used for small molecule imprinting. The 144 
advantages of using surface imprinting when preparing protein MIPs has been 145 
described in ref [32]. This review included sections on SPE, mainly of small 146 
molecular mass analytes. The use of carbon nanofibres, nanodiamonds, 147 
fullerenes, carbon nanotubes, graphene and graphene oxide were evaluated by 148 
ref [33] as possible materials for isolation and pre-concentration of proteins and 149 
where MIPs can improve selectivity. 150 
 151 
There have been several reviews of the use of MIPs for SPE. For example, 152 
Augusto et al. 2013 [34] considered the merits of immunoaffinity, MIPs, 153 
aptamers, carbon nanotubes and other nanomaterials. These give numerous 154 
examples of the use of MIPs to extract small molecular mass compounds but 155 
generally give few examples of macromolecule extraction. SPE can be carried 156 
out in several formats. Examples include a conventional small syringe packed 157 
with the MIP, coated fibres, capillaries, surface coated particles, coated stir bars, 158 
membranes, magnetic beads and nanoparticles [35]. All have advantages and 159 
disadvantages and these were evaluated. Hu et al. 2013 also emphasised that 160 
the major obstacles include the difficulty of finding optimised conditions for 161 
selective extraction, compatibility with aqueous solutions and the low number of 162 
binding sites obtained [35]. 163 
 164 
Schirhagl et al. 2014 [36] reviewed the particular approaches to imprinting large 165 
biomolecules and highlighted the advantages of using more flexible polymers 166 
than the rigid polymers used for small molecules. The review covered methods of 167 
synthesis, template removal, applications using various methods (optical, 168 
electrical and mass sensitive) of signal production in sensors, separation science 169 
and possibilities in drug discovery. The article concluded that selectivities 170 
obtained for large biomolecules are still not as good as those for small drug like 171 
molecules. 172 
 173 
One interesting approach recently reported was the use of a surface imprinted 174 
polymer using myoglobin as the template [37]. The MIP allowed selective capture 175 
and release of the target using temperature, rather than the much more 176 
widespread use of a change of solvent or pH.  177 
 178 
The basic principle of using a selective extraction followed by desorption into a 179 
chromatograph with an MS detector or other instrumental technique is attractive, 180 
as accurate measurement and a high degree of specificity or identification can be 181 
achieved. Again the evidence quoted in scientific literature for a MIP effect is 182 
often that the macromolecule is extracted with greater recovery from the MIP 183 
than the NIP and selectivity to similar molecules in terms of molecular mass, 184 
function or isoelectric potential. Conclusive evidence of a molecular imprinting 185 
effect has been questioned [38]. Although comparison of MIP to NIP is some 186 
evidence of a MIP effect the non-specific binding to the NIP does suggest that 187 
further studies such as structural characterization would be helpful. Non-specific 188 
binding will prove to be a particular obstacle to widespread acceptance when 189 
complex samples such as biofluids are processed. Ultimately, the crucial point is 190 
not whether the selective capture is an effect requiring specific interactions at 191 
specific points on the polymer; rather, it is whether or not MIP-based selective 192 
extraction provides improvement in the analytical methods developed. This would 193 
then need widespread uptake to become completely convincing. 194 
This article will review recent examples in the development of the use MIPs for 195 
selective extraction or enrichment of proteins and other large biomolecules 196 
appropriate to biological samples. A very extensive collection of articles 197 
describing the preparation or use of MIPs in all their applications is listed online 198 
[39]. The majority of applications of MIPs are in the area of separation science or 199 
sensors. The reality that there are few examples of methods based on MIPs for 200 
selective extraction of macromolecules suggests something of an unmet need 201 
here. 202 
 203 
Examples of extraction/enrichment of macromolecules using MIPs (see  204 
also Table 1) 205 
Qadar et al. 2014 [40] developed MIPs to the nonapeptide progastrin releasing 206 
peptide (ProGRP), a possible biomarker for small cell lung cancer. A range of 207 
acrylamide monomers were evaluated in the SPE format with fractions analysed 208 
by HPLC-UV. Selectivity was checked against 4 other peptides. In a follow up 209 
paper [41] this group applied the optimised protocol to enrich the peptide from 210 
fortified serum. The limit of detection from the optimised protocol was reported to 211 
be about 600 pM.  The elution protocol used 80% acetonitrile as elution solvent. 212 
The MIP retained the targeted peptide more than the NIP, which nonetheless 213 
does show non-specific binding. Importantly an example showed a much cleaner 214 
chromatogram for the MIP compared with the NIP. Although a nonapeptide rather 215 
than a protein, this paper illustrates the potential of a method based on selective 216 
SPE with a MIP followed by LC-MS for an important low abundance biomarker. 217 
There are several other examples of polypeptide MIPs [30, 40, 42, 43]. Shinde et 218 
al. 2012 [44] described how an SPE MIP format could distinguish between 219 
sulpho- and phosphorylated peptides. Fractions were analysed by HPLC and 220 
matrix assisted laser desorption ionisation (MALDI) to confirm the elution fraction 221 
contents. 222 
 223 
Qin et al. 2009 [45] showed the possibility of enriching lysozyme from aqueous 224 
and biological samples – in this case egg white. N-(4-vinyl)-benzyl iminodiacetic 225 
acid (VBIDA) was co-polymerized with N-isopropylacrylamide (NiPAm) and AAm 226 
in the presence of copper (Cu2+) ions. Greater adsorption capacity was shown for 227 
the lysozyme template than for several other proteins (cytochrome C (CytC), 228 
ribonuclease A (RNase A), ovalbumin, bovine haemoglobin (BHb), BSA, and 229 
glucose oxidase). A gel electrophoresis figure showed enrichment of the 230 
lysozyme from diluted egg white. There is growing interest in incorporating metal 231 
ions (through complexation) to improve the binding affinity of MIP for a target 232 
protein [46]. The electron donating effect of amino groups of the protein to the 233 
metal centre offers an additional anchor point for the protein to dock within the 234 
vicinity of the cavity.  235 
 236 
Gao et al. 2010 [47] prepared a surface modified MIP to lysozyme using 237 
methacrylic acid (MAA) as functional monomer and hydroxyethylmethacrylate 238 
(HEMA)/ N-vinylpyrrolidone (VNP) as cross-linked microspheres. Although 239 
biological samples were not evaluated, dynamic binding curves clearly illustrated 240 
the delayed elution of the lysozyme compared to bovine haemoglobin.  241 
 242 
Gai et al. 2010 and 2011 [48, 49] prepared MIPs to BHb and lysozyme. The 243 
lysozyme MIP was surface imprinted and showed greater selectivity for the 244 
lysozyme compared with BHb, myoglobin, BSA, Trypsin inhibitor (TI) and CytC. 245 
The BSA MIP similarly showed greater selectivity in adsorption experiments, 246 
potentially applicable as a sample preparation/enrichment method. Non-specific 247 
binding to NIP was also shown which could lessen the use of such a MIP for 248 
accurate measurement. 249 
 250 
Dan et al. 2013 [28] reported MIPs to ovalbumin using the polysaccharide 251 
chitosan and acrylamide as monomers and described extensive optimisation of 252 
synthesis. Selectivity was ascertained by comparing MIP rebinding with the non-253 
cognate proteins BSA, BHb and lysozyme. They also looked at surface 254 
morphology using several techniques.  Gels using chitosan and acrylic acid (AA) 255 
and MAA showed the best potential but non-selective binding to NIP and 256 
selectivity to other proteins still needs addressing. Biological samples were not 257 
evaluated. 258 
 259 
Wan et al. 2015 [50] showed how a polydopamine MIP surface imprinted on 260 
nanoparticles could enrich lysozyme spiked diluted egg white samples. The MIP 261 
was compared to NIP and cross reactivity studies versus five proteins (RNase A, 262 
BHb, BSA, trypsin and CytC) demonstrated preferential binding to the target 263 
protein. Samples were analysed using MALDI-TOF. 264 
 265 
Deng et al. 2011 [51] prepared a monolithic MIP to BSA using a freeze thawing 266 
polymerisation method with acrylamide as the monomer. Both HPLC and SPE 267 
demonstrated a greater retention for the BSA versus Hb. A gel electrophoresis 268 
plate showed a SPE extract enriched with the target protein compared to 269 
carbonic anhydrase, lysozyme, BSA, and trypsin. The MIP column showed the 270 
BSA, the NIP column showed none of the aforementioned proteins. 271 
 272 
Lin et al. 2013 [52] described the selective extraction of horseradish peroxidise 273 
(HRP) from spiked human serum samples. Dopamine was the functional 274 
monomer used for MIP preparation. Although the paper was mainly concerned 275 
with a monolithic HPLC column it also described the use of the MIP approach in 276 
SPME format. It showed a gel electrophoresis plate with significantly enriched 277 
HRP. 278 
 279 
Namatozola et al. 2014 [53] used AAm to prepare MIPs for human serum 280 
albumin (HSA) and IgG. Part of their article described the evaluation using SPE. 281 
Comparison of MIP and NIP shows a slightly increased recovery in the elution 282 
fraction for the imprinted protein particularly for the IgG. For both MIPs much of 283 
the protein was eluted in load and wash fractions suggesting very low selective 284 
binding capacities within the MIP. 285 
 286 
Solemani et al. 2012 [54] described the preparation of a BSA MIP under the 287 
conditions normally used for small molecule analytes. They evaluated the MIP in 288 
SPE format, optimising the flow rate, the effect of pH, ionic strength, sample 289 
volume and different ratios of methanol/acetonitrile on elution. After optimisation 290 
with standard solutions, more challenging solutions such as serum, urine, whey 291 
and milk were applied. MIPs were compared with NIPs for recovery. It should be 292 
noted that elution fractions from the SPE columns were evaluated by UV-Vis 293 
spectrophotometry not by chromatography or MS. The possibility of denaturation 294 
of the BSA during MIP synthesis or the analytical protocol cannot be discounted 295 
and could be evaluated by, for example, using circular dichroism spectroscopy to 296 
assess the nature of the protein during and following the MIP production process 297 
[55, 56]. 298 
 299 
Liu et al. 2014 [57] prepared MIPs for extraction of HSA using porcine serum 300 
albumin as a dummy template with methacrylate monomers. The aim of this work 301 
was to selectively extract high abundance protein that was not the analyte of 302 
interest, thereby enhancing the detection limits of low abundance proteins of 303 
interest. Much higher binding affinity for the desired protein was obtained 304 
compared with β-lactoglobulin, CytC or ribonuclease B. The use of a dummy 305 
template was common with small molecule SPE. It involved the use of a 306 
structural analogue of the target analyte to form the MIP. To date it is much less 307 
common with macromolecules. 308 
 309 
An example of virus imprinting was shown by Sykora et al. 2015 [58] where 310 
preliminary results indicated the synthesis of surface MIPs to a Human Norovirus 311 
strain. They pointed out some of the difficulties of this type of work. Quite apart 312 
from the problem of biomolecule stability, the need to use large amounts of 313 
pathogenic virus in the MIP synthesis stage restricts this type of work. This issue 314 
was overcome by using a genetically modified virus-like particle as the template. 315 
The paper showed a much larger binding to the MIP compared with the NIP. 316 
Field emission scanning electron microscopy pictures were also shown as 317 
evidence of MIP structure. 318 
 319 
Comments 320 
Sample preparation includes trying to isolate the analyte to improve detection 321 
limits, especially if the analyte is at very low concentration when there is plenty of 322 
sample. It can also include trying to remove matrix components that interfere 323 
even if they do not give a direct signal to the detector, for example ion 324 
suppression in MS.  325 
 326 
In contrast to MIPs, antibodies are extensively used commercially especially in 327 
clinical (bio) chemistry laboratories. There are examples where MIPs have been 328 
shown to replace antibodies in clinical tests [13, 59]. So their increasing use for 329 
selective extraction of macromolecules is anticipated. Whether it will be for 330 
special applications or widespread depends on the reality of commercially 331 
developing suitable products. The virtues of combining immunoaffinity sample 332 
preparation with MS detection have been highlighted in a special issue of 333 
Bioanalysis especially in the overview given by Ackerman [60]. The advantages 334 
offered by biological antibodies will be potentially superseded if suitable MIPs can 335 
be reliably produced. The attraction of specific analyte capture, trace enrichment 336 
from a large volume and then release into a small volume of liquid compatible 337 
with injection into an LC-MS is clear. The use of antibodies for this is increasing. 338 
If this type of procedure could be achieved with MIPs this would be an even more 339 
attractive approach. 340 
 341 
With proteins and other large biomolecules analyte stability is a problem, so 342 
aqueous based SPE protocols are essential. Several papers look at morphology 343 
or cavity size, but to be of use to bioanalysts with real measurements to make 344 
and defend this ultimately depends on how clean the samples are and the 345 
reproducibility of results that is demanded by the end user. One of the drawbacks 346 
with the use of MIPs has been the reality that they are not yet as specific as 347 
biologically developed antibodies. Whereas Kd values for antibody-antigen 348 
interactions are of the order of 10-9 M, the majority of MIP-antigen interactions 349 
are still at the 10-6-10-7 M range, However, recently Piletsky’s group has 350 
developed a technique for the mass production of nanosized MIPs (plastic 351 
antibodies) reporting Kd values matching biological antibodies [61]. When used 352 
as reagents for SPE followed by a specific and sensitive end-step such as LC-353 
MS the lack of high affinity MIPs is less of a drawback. Potentially they can offer 354 
enough selectivity in extraction to provide a clean enough sample for the 355 
chromatography or other measurement. The reality that there are currently few 356 
examples of this approach suggests it is worthy of more effort. 357 
 358 
Peptides are not as challenging because they are more stable than proteins and 359 
also less expensive in terms of requiring a relatively large amount of template. 360 
Other similar approaches for selective extraction have also been developed. The 361 
use of aptamers (short single stranded DNA or RNA molecules) has been 362 
reviewed by [62, 63] including their use in SPE format. The importance of 363 
measuring new therapeutic agents or small abundance protein biomarkers 364 
means that the quest for improved methods of selective enrichment/clean-up will 365 
continue. Other areas where MIPs may show promise include virus imprinting 366 
[64-66] where preliminary experiments showed that tobacco mosaic virus could 367 
be imprinted using polyallylamine. 368 
 369 
Difficulties such as the need for a large amount of template for MIP synthesis, 370 
reliable and complete template removal, minimisation of non-specific binding, a 371 
reasonable shelf-life and commercial availability of quality controlled products 372 
that are suitable for rebinding in aqueous solutions still need to be overcome. 373 
Nonetheless the approach of selective (enough) extraction followed by HPLC-MS 374 
is an attractive proposition in bioanalysis. Hence, the development and validation 375 
to regulatory authority guidelines of macromolecule MIPs is tentatively awaited. 376 
 377 
Conclusions 378 
Molecularly imprinted polymers offer an alternative approach to biological 379 
antibodies for selective capture reagents in bioanalytical chemistry. Most of the 380 
developments in MIPs have involved small molecules particularly drugs and 381 
metabolites. Although several different applications have been proposed, none 382 
have come into widespread routine use in laboratories. Use as selective sorbents 383 
for SPE have been the most promising area. Even in this area, uptake has been 384 
slow. This is in part due to the advent of techniques such as LC-MS seemingly 385 
requiring less rigorous sample preparation requirements. It is also, in part, 386 
caused by the nature of the technique. If you develop a product that is specific to 387 
only one drug or class of drug – it is not going to attract a big market. However 388 
generic protocols would be helpful here. 389 
  390 
There is growing interest in accurate measurement of proteins and other 391 
macromolecules or biological entities such as viruses. These are being 392 
introduced as new drugs or being validated as biomarkers both for drug efficacy 393 
and diagnostics. Not surprisingly, MIPs are being produced to macromolecules 394 
and are now being evaluated for use in sensors and for sample preparation. 395 
Selective extraction both for analytical and preparative purposes is worthy of 396 
more research as there are few examples of macromolecule determination in 397 
biological samples. Methods proposed will need to be subject to the rigorous 398 
validation protocols required by regulatory authorities, not just publication in 399 
academic journals. 400 
 401 
Future Perspectives 402 
The determination of large molecules in biological fluids will continue to be an 403 
area of growing importance. Problems with determining intact macromolecules 404 
will present greater challenges than for small molecules not least due to their lack 405 
of stability. Improvements in the preparation of macromolecular MIPs are 406 
needed. This will facilitate investigations into the use of such selective reagents 407 
for improved methods of sample preparation. These could then be utilised along 408 
with methods such as LC-MS to provide accurate quantification at low 409 
concentrations in biological fluids. 410 
 411 
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Table 1 – Example of analytes imprinted within a varied mix of matrices and 416 
monomer/cross-linker combinations.  417 
Analyte Matrix Monomer Cross-linker Validation Ref 
BHb Aqueous buffers AAm MBAA MIP vs NIP Selectivity vs BSA [49] 
Lysozyme Aqueous and diluted egg white NiPAm/AAm MBAA 
MIP vs NIP 
Selectivity vs BSA, 
Mb, BHb, TI, CytC 
[48] 
Ovalbumin Aqueous non-biological 
Chitosan/AA,AAm, 
MAA MBAA 
MIP vs NIP 
Selectivity vs BSA, 
BHb, lysozyme 
[28] 
ProGRP Aqueous non-biological EAMA DVB 
MIP vs NIP 
Selectivity vs 3 
other poly peptides 
[40, 41] 
Lysozyme Aqueous buffers VBDIA/ NiPAm/AAm Plus Cu ions MBAA 
MIP vs NIP 
Selectivity vs 
CytC, RNasaA, 
OB, BSA, Hb, GOx 
[45] 
Lysozyme Aqueous and  diluted egg white Dopamine Not reported 
MIP vs NIP and 
selectivity vs CytC, 
RNase A, BHb, 
BSA, CytC 
[50] 
HPR Spiked human serum Dopamine PETA 
HSA, IgG, Trf and 
other serum 
proteins 
[52] 
HSA, IgG Aqueous buffers AAm MBAA MIP vs NIP [53] 
BSA Aqueous buffers AAm MBAA 
MIP vs NIP and 
selectivity vs CA,  
lysozyme, BSA, 
and trypsin 
[51] 
BSA Aqueous buffers, serum, urine 2VP EGDMA MIP vs NIP [54] 
Acrylamide (AAm); Acrylic acid (AA); Methylacrylic acid (MAA); N-(2-Aminoethyl methacrylamide hydrochloride 
(EAMA); N-isopropylacrylamide (NiPAm); Divinyl benzene (DVB); N,N-methylenebisacrylamide (MBAA); N-(4-vinyl)-
benzyl iminodiacetic acid (VBIDA); 2-vinylpyridine (2VP); Cytochrome C (CytC); Bovine haemoglobin (BHb); Bovine 
serum albumin (BSA); Myoglobin (Mb); Trypsin inhibitor (TI); Glucose oxidase (GOx); Carbonic Anhydrase (CA); 
Ovalbumin (OB); Pentaerythritol triacrylate (PETA); Horseradish peroxidase (HPR); Transferrin (Trf); Ribonuclease A 
(RNase A); Ethylene glycol dimethylacrylate (EGDMA). 
Executive Summary 418 
Background 419 
 The measurement of drugs, metabolites and endogenous compounds is a 420 
very challenging area for Analytical Chemists. The most common methods 421 
involve some form of extraction to give sample clean up and pre-422 
concentration. This is then followed by injection into a gas or liquid 423 
chromatograph and measurement using a variety of detectors but most 424 
commonly nowadays mass spectrometry. 425 
 As demands for better sensitivity are a challenge methods of selective 426 
extraction have been explored. One of the most attractive of these has 427 
been the use of immobilised antibodies to selectively extract drugs and 428 
metabolites using solid phase extraction. 429 
 430 
Molecularly Imprinted Polymers 431 
 MIPs are synthetic polymers formed around a template molecule (the 432 
analyte). These are then used as reagents to selectively rebind the analyte 433 
during sample preparation. They are much cheaper than biological 434 
antibodies and are more stable. 435 
 There are many literature applications using MIPs to extract small 436 
molecular mass drugs and metabolites but they are not in common use in 437 
industrial laboratories. 438 
 439 
MIPs for extraction/enrichment of macromolecules 440 
 With the development of macromolecules as candidate drugs and 441 
biomarkers there has been increased interest in developing selective 442 
extraction to large molecules. 443 
 The use of soft gels, where the MIPs are formed in aqueous solutions is 444 
much more applicable to biomolecules which are generally not stable in 445 
other solvents. 446 
 447 
Examples of extraction/enrichment of macromolecules using MIPs 448 
 Examples of selective binding of a number of macromolecules are given. 449 
These include peptides and polypeptides, lysozyme, bovine haemoglobin, 450 
bovine serum albumin, ovalbumin, horseradish peroxidise, human serum 451 
albumin, and viruses. 452 
 453 
Comments 454 
 The combination of selective extraction along with HPLC-MS to measure 455 
macromolecules is very attractive.  456 
 However there are as yet few examples where this has been achieved 457 
with MIPs as opposed to biological antibodies. 458 
 There are some questions as to whether or not a MIP effect is as selective 459 
as desired. 460 
 461 
Conclusions 462 
 Use of selective extraction is an area likely to grow as more 463 
macromolecular drug candidates and biomarkers are developed.  464 
465 
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